glp-1 and vision drugs linked to rare loss: JAMA study | Pharmavoice.in posted on the topic The Ophthalmologist | Wegovy and
Description
Lancet Neurol (2015) 14(9):94555

In this trial, at 60 weeks, the exenatide group showed a significant improvement in MDS-UPDRS Part III scores compared to the placebo group among the 62 recruited patients (80)
TLR2: Toll-like receptor 2

Shotsy even acts as a custom GLP-1 alarm clock: Enter your dosage and timing, and itll send you reminders to take your medication
Ishy PL, Knop FK, Broberg BV, Bak N, Andersen UB, Jrgensen NR, et al
